Subarachnoid hemorrhage
Subarachnoid hemorrhage (SAH) is a type of hemorrhagic cerebrovascular disease, which is divided into primary and secondary types. Primary subarachnoid hemorrhage is caused by ruptured blood vessels on the surface and base of the brain, and blood flows directly into the subarachnoid space. It is also called spontaneous SAH. Secondary SAH is caused by brain parenchymal or ventricular hemorrhage, traumatic subdural or epidural hemorrhage flowing into the subarachnoid space. Subarachnoid hemorrhage is one of the most common emergencies in neurology, and the incidence rate accounts for 6% to 10% of acute cerebrovascular diseases.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
It is more common in young adults aged 30 to 40, and some... -
Related symptoms:
Symptoms of meningeal irritation Localizing neurological signs Hemiplegia Epilepsy and epileptic seizures Headache
Related Drugs
Nitrendipine
Indication: Hypertension, subarachnoid hemorrhage.
Manufacturer:
Henan Qixin Pharmaceutical Co., Ltd.
Nitrendipine
Indication: Hypertension, subarachnoid hemorrhage.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Fasudil Hydrochloride Injection
Indication: Used to improve the symptoms of ischemic cerebrovascular disease caused by cerebral vasospasm after subarachnoid hemorrhage.
Manufacturer:
Tianjin Chase Sun Pharmaceutical Co., Ltd.
Fasudil Hydrochloride Injection
Indication: Improvement of symptoms of ischemic cerebrovascular disease caused by cerebral vasospasm after subarachnoid hemorrhage.
Manufacturer:
Chengdu Easton Bio Pharmaceuticals Co., Ltd.
Fasudil Hydrochloride Injection
Indication: Improvement of symptoms of ischemic cerebrovascular disease caused by cerebral vasospasm after subarachnoid hemorrhage.
Manufacturer:
Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
Fasudil Hydrochloride Injection
Indication: Improvement of symptoms of ischemic cerebrovascular disease caused by cerebral vasospasm after subarachnoid hemorrhage.
Manufacturer:
GRAND PHARMACEUTICAL(China) Co., Ltd.
Ozagrel Sodium Injection
Indication: Used to treat acute thrombotic cerebral infarction and movement disorders associated with cerebral infarction, and to improve cerebral vasospasm and contraction and concurrent cerebral ischemia symptoms after subarachnoid hemorrhage surgery.
Manufacturer:
Shenyang Yaoda Leiyunshang Pharmaceutical Co., Ltd.
Ozagrel Sodium Injection
Indication: Used to treat acute thrombotic cerebral infarction and movement disorders associated with cerebral infarction, and to improve cerebral vasospasm and contraction and concurrent cerebral ischemia symptoms after subarachnoid hemorrhage surgery.
Manufacturer:
Shanxi Deyuantang Pharmaceutical Co., Ltd.
Nimodipine
Indication: This product is used to prevent and treat ischemic nerve damage caused by cerebral vasospasm after subarachnoid hemorrhage, as well as senile brain function damage, migraine, sudden deafness, etc.
Manufacturer:
Xi'an Bo'ai Pharmaceutical Co., Ltd.
Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.